A Phase III Randomized Clinical Trial of a 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzolamide Fixed Combination, Preservative-Free Ophthalmic Solution vs. 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzolamide Fixed Combination in Patients with Controlled Primary Open-Angle Glaucoma

類似資料

• Comparison of timolol 0.5% + brimonidine 0.2% + dorzolamide 2% versus timolol 0.5% + brimonidine 0.2% in a Mexican population with primary open-angle glaucoma or ocular hypertension
  著者:: Baiza-Durán, Leopoldo Martín, 等
  出版事項: (2012)
• Fixed combination of topical brimonidine 0.2% and timolol 0.5% for glaucoma and uncontrolled intraocular pressure
  著者:: Lee, Anne J, 等
  出版事項: (2008)
• Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study
  著者:: García-López, Alfonso, 等
  出版事項: (2014)
• Effect of 0.2% brimonidine and 0.2%/0.5% brimonidine-timolol on intraocular pressure and pupil size in normal equine eyes
  著者:: VonZup, M., 等
  出版事項: (2017)
• Evaluation of the Effectiveness of Using a Fixed Combination of Dorzolamide 2.0 % and Timolol 0.5 % in Primary Open-­Angle Glaucoma
  著者:: S. S. Khaldeev, 等
  出版事項: (2024-06-01)